Cognetivity Neurosciences Ltd.
CGN
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.50M | -1.45M | -1.56M | -1.90M | -1.35M |
| Total Depreciation and Amortization | 5.10K | 5.70K | 5.10K | 3.60K | 4.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 961.20K | 1.01M | 1.07M | 942.20K | -30.30K |
| Change in Net Operating Assets | 545.90K | -64.70K | -641.40K | -288.30K | 1.21M |
| Cash from Operations | 12.50K | -501.20K | -1.13M | -1.24M | -168.90K |
| Capital Expenditure | -- | 800.00 | -800.00 | -100.00 | 900.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.70K | -4.70K | -2.60K | 3.20K | -10.10K |
| Cash from Investing | -13.70K | -3.90K | -3.40K | 3.10K | -9.20K |
| Total Debt Issued | -- | -- | -- | -152.90K | 2.30K |
| Total Debt Repaid | -11.60K | -11.30K | -- | 10.80K | 200.00 |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -13.40K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 4.30M |
| Repurchase of Preferred Stock | -- | -- | -- | -50.40K | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.50K | -8.50K | -- | -152.80K | 3.23M |
| Foreign Exchange rate Adjustments | -100.00 | -4.00K | 4.40K | 1.20K | -500.00 |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -9.90K | -517.50K | -1.13M | -1.39M | 3.05M |
